Lyka Labs

{
  "main_header": {
    "sid": 189121,
    "name": "Lyka Labs",
    "stock_name": "Lyka Labs",
    "full_name": "Lyka Labs Ltd",
    "name_url": "stocks-analysis/lyka-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "67.12",
    "chg": -1.38,
    "chgp": "-2.01%",
    "dir": -1,
    "prev_price": "68.50",
    "mcapval": "251.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 500259,
    "symbol": "LYKALABS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE933A01014",
    "curr_date": "Jun 23, 02:32 PM",
    "curr_time": "14:38 PM",
    "last_traded_at": "Jun 23, 02:32 PM IST",
    "bse_nse_vol": "22.22 k",
    "exc_status": "Active",
    "traded_date": "Jun 23, 2026",
    "traded_date_str": "2026 06 23",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lyka-labs-189121-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lyka Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-4068950",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LykaLabsLtd_mojoScore_4068950.png",
        "date": "2026-06-23 10:10:32",
        "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Jan 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 23 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Lyka Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-4046502",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LykaLabsLtd_mojoScore_4046502.png",
        "date": "2026-06-11 10:10:22",
        "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Lyka Labs Ltd Locks at Upper Circuit With 8.19% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-surges-to-upper-circuit-on-robust-buying-momentum-4043785",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LykaLabsLtd_stocks_hitting_upper_circuit_4043785.png",
        "date": "2026-06-10 10:00:10",
        "description": "At Rs 77.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Lyka Labs Ltd locked at its upper circuit of 8.19% on 10 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Lyka Labs Ltd Locks at Upper Circuit With 9.99% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-surges-to-upper-circuit-on-robust-buying-momentum-4041254",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/LykaLabsLtd_stocks_hitting_upper_circuit_4041254.png",
        "date": "2026-06-09 14:00:09",
        "description": "At Rs 70.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Lyka Labs Ltd locked at its upper circuit of 9.99% on 09 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Lyka Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-4019986",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LykaLabsLtd_mojoScore_4019986.png",
        "date": "2026-05-29 10:10:22",
        "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Jan 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 29 May 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Are Lyka Labs Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-lyka-labs-ltd-latest-results-good-or-bad-4014842",
        "imagepath": "",
        "date": "2026-05-26 19:24:14",
        "description": "Lyka Labs Ltd's latest financial results for Q4 FY26 reveal a concerning operational landscape. The company reported a net loss of ₹7.61 crore, a significant reversal from profitability in the same quarter last year, which indicates a severe decline in financial health. Revenue for the quarter was ₹28.03 crore, reflecting a year-on-year decrease of 16.15%, marking the lowest quarterly revenue in seven quarters. This decline suggests persistent demand weakness and potential market share erosion.\n\nThe operating margin turned deeply negative at -23.05%, the lowest level recorded, indicating severe cost pressures and operational inefficiencies. Additionally, the profit before tax swung to a loss of ₹8.59 crore, further underscoring the operational challenges faced by the company. Employee costs surged significantly, contributing to a ballooning employee cost-to-sales ratio of 46.06%, raising questions about wor..."
      },
      {
        "title": "Lyka Labs Q4 FY26: Steep Losses Amid Operational Crisis Signal Deepening Distress",
        "link": "https://www.marketsmojo.com/news/result-analysis/lyka-labs-q4-fy26-steep-losses-amid-operational-crisis-signal-deepening-distress-4013240",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LykaLabs_quaterlyResult_4013240.png",
        "date": "2026-05-25 22:30:51",
        "description": "Lyka Labs Ltd. plunged into severe operational distress in Q4 FY26, reporting a consolidated net loss of ₹7.61 crores compared to a profit of ₹1.77 crores in Q4 FY25—a staggering deterioration of 529.94%. The micro-cap pharmaceutical company, with a market capitalisation of ₹221.00 crores, saw revenues contract 16.15% year-on-year to ₹28.03 crores whilst operating margins collapsed into deeply negative territory at -23.05%, marking the worst quarterly performance in recent history."
      },
      {
        "title": "Lyka Labs Ltd Locks at Lower Circuit With 4.69% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lyka-labs-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3996995",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LykaLabsLtd_stocks_hitting_lower_circuit_3996995.png",
        "date": "2026-05-18 12:00:05",
        "description": "At Rs 58.73, Lyka Labs Ltd locked at its lower circuit on 18 May 2026, falling 4.69% within a 5% price band. The session ended with unfilled supply as sellers queued at the floor price but buyers remained absent, freezing trading and highlighting the liquidity challenges faced by this micro-cap pharmaceutical stock."
      },
      {
        "title": "Lyka Labs Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lyka-labs-ltd-is-rated-strong-sell-3996764",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/LykaLabsLtd_mojoScore_3996764.png",
        "date": "2026-05-18 10:10:16",
        "description": "Lyka Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Jan 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 18 May 2026, providing investors with the latest insights into its performance and prospects."
      }
    ],
    "total": 419,
    "sid": "189121",
    "stock_news_url": "https://www.marketsmojo.com/news/lyka-labs-189121"
  },
  "announcements": [
    {
      "caption": "Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 - GST",
      "datetime": "17-Jun-2026",
      "details": "As per the letter attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment",
      "datetime": "12-Jun-2026",
      "details": "As per the letter attached",
      "source": "BSE"
    },
    {
      "caption": "Clarification sought from Lyka Labs Ltd",
      "datetime": "11-Jun-2026",
      "details": "The Exchange has sought clarification from Lyka Labs Ltd on June 11 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lyka Labs Ltd is Rated Strong Sell

2026-06-23 10:10:32

Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Jan 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 23 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Lyka Labs Ltd is Rated Strong Sell

2026-06-11 10:10:22

Lyka Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 11 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Lyka Labs Ltd Locks at Upper Circuit With 8.19% Gain — Buyers Queue, Sellers Absent

2026-06-10 10:00:10

At Rs 77.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Lyka Labs Ltd locked at its upper circuit of 8.19% on 10 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Lyka Labs Ltd Locks at Upper Circuit With 9.99% Gain — Buyers Queue, Sellers Absent

2026-06-09 14:00:09

At Rs 70.05, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Lyka Labs Ltd locked at its upper circuit of 9.99% on 09 Jun 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Lyka Labs Ltd is Rated Strong Sell

2026-05-29 10:10:22

Lyka Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Jan 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 29 May 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Are Lyka Labs Ltd latest results good or bad?

2026-05-26 19:24:14

Lyka Labs Ltd's latest financial results for Q4 FY26 reveal a concerning operational landscape. The company reported a net loss of ₹7.61 crore, a significant reversal from profitability in the same quarter last year, which indicates a severe decline in financial health. Revenue for the quarter was ₹28.03 crore, reflecting a year-on-year decrease of 16.15%, marking the lowest quarterly revenue in seven quarters. This decline suggests persistent demand weakness and potential market share erosion. The operating margin turned deeply negative at -23.05%, the lowest level recorded, indicating severe cost pressures and operational inefficiencies. Additionally, the profit before tax swung to a loss of ₹8.59 crore, further underscoring the operational challenges faced by the company. Employee costs surged significantly, contributing to a ballooning employee cost-to-sales ratio of 46.06%, raising questions about wor...

Read full news article

Lyka Labs Q4 FY26: Steep Losses Amid Operational Crisis Signal Deepening Distress

2026-05-25 22:30:51

Lyka Labs Ltd. plunged into severe operational distress in Q4 FY26, reporting a consolidated net loss of ₹7.61 crores compared to a profit of ₹1.77 crores in Q4 FY25—a staggering deterioration of 529.94%. The micro-cap pharmaceutical company, with a market capitalisation of ₹221.00 crores, saw revenues contract 16.15% year-on-year to ₹28.03 crores whilst operating margins collapsed into deeply negative territory at -23.05%, marking the worst quarterly performance in recent history.

Read full news article

Lyka Labs Ltd Locks at Lower Circuit With 4.69% Loss — Sellers Queue, No Buyers in Sight

2026-05-18 12:00:05

At Rs 58.73, Lyka Labs Ltd locked at its lower circuit on 18 May 2026, falling 4.69% within a 5% price band. The session ended with unfilled supply as sellers queued at the floor price but buyers remained absent, freezing trading and highlighting the liquidity challenges faced by this micro-cap pharmaceutical stock.

Read full news article

Lyka Labs Ltd is Rated Strong Sell

2026-05-18 10:10:16

Lyka Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Jan 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below are based on the company’s current position as of 18 May 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

View All News